$22.80
+1.55 (+7.29%)
Open$21.32
Previous Close$21.25
Day High$22.95
Day Low$21.07
52W High$6.84
52W Low$3.13
Volume—
Avg Volume165.3K
Market Cap195.43M
P/E Ratio55.15
EPS$0.11
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
-65.2% upside
Current
$22.80
$22.80
Target
$7.94
$7.94
$5.53
$7.94 avg
$9.87
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 55.50M | 49.01M | 58.73M |
| Net Income | -3,521,463 | -2,802,997 | -4,374,334 |
| Profit Margin | -6.3% | -5.7% | -7.5% |
| EBITDA | -5,026,082 | -4,562,575 | -6,395,991 |
| Free Cash Flow | -3,518,270 | -4,055,082 | -5,438,545 |
| Rev Growth | +7.8% | +7.4% | -1.1% |
| Debt/Equity | 0.88 | 0.82 | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |